Cardiovascular disease and arsenic exposure in Inner Mongolia, China: A case control study

Environmental Health: A Global Access Science Source

Volumn 14, Issue 1, 2015, Pages

  Wade, Timothy J ^a   Xia, Yajuan ^b   Mumford, Judy ^a   Wu, Kegong ^b   Le, X Chris ^c   Sams, Elizabeth ^a   Sanders, William E ^d  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b Inner Mongolia Center for Endemic Disease Control and Research   (China)

^c UNIVERSITY OF ALBERTA   (Canada)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Arsenic; Cardiovascular disease; China; Drinking water

Indexed keywords

ARSENIC; DRINKING WATER; WELL WATER; WATER POLLUTANT;

ARSENIC; CARDIOVASCULAR DISEASE; DISEASE CONTROL; DRINKING WATER; HEALTH RISK; HOSPITAL SECTOR; POLLUTION EXPOSURE; STANDARDIZATION;

ACUTE HEART INFARCTION; ADULT; AGED; ALLERGY; ARTICLE; BEEF; BODY MASS; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHINA; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FAMILY HISTORY; FEMALE; GASTROINTESTINAL SYMPTOM; HEART DISEASE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HYPERTENSION; INFLUENZA; INJURY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PORK; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; THORAX PAIN; WATER CONTAMINATION; WATER SAMPLING; WATER SUPPLY; ADOLESCENT; CARDIOVASCULAR DISEASES; CHEMICALLY INDUCED; INCIDENCE; MIDDLE AGED; TOXICITY; WATER POLLUTANT; YOUNG ADULT;

CHINA; NEI MONGGOL;

ADOLESCENT; ADULT; AGED; ARSENIC; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHINA; DRINKING WATER; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; WATER POLLUTANTS, CHEMICAL; WATER WELLS; YOUNG ADULT;

EID: 84928410317     PISSN: None     EISSN: 1476069X     Source Type: Journal    
DOI: 10.1186/s12940-015-0022-y     Document Type: Article

References (44)

1. Chen CJ, Chuang YC, Lin TM, Wu HY. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res. 1985;45(11 Pt 2):5895-9.
2. Hopenhayn-Rich C, Biggs ML, Fuchs A, Bergoglio R, Tello EE, Nicolli H, et al. Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology. 1996;7(2):117-24.
3. Smith AH, Goycolea MH, aque R, Biggs ML. Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am J Epidemiol. 1998;147(7):660-9.
4. Mumford JL, Wu K, Xia Y, Kwok R, Yang Z, Foster J, et al. Chronic arsenic exposure and cardiac repolarization abnormalities with QT interval prolongation in a population-based study. Environ Health Perspect. 2007;115(5):690-4.
5. Tseng CH, Chong CK, Tseng CP, Hsueh YM, Chiou HY, Tseng CC, et al. Long-term arsenic exposure and ischemic heart disease in arseniasis-hyperendemic villages in Taiwan. Toxicol Lett. 2003;137(1-2):15-21.
6. Chen CJ, Chiou HY, Chiang MH, Lin LJ, Tai TY. Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure. Arterioscler Thromb Vasc Biol. 1996;16(4):504-10.
7. Chen Y, Graziano JH, Parvez F, Liu M, Slavkovich V, Kalra T, et al. Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: prospective cohort study. BMJ. 2011;342:d2431.
8. Yuan Y, Marshall G, Ferreccio C, Steinmaus C, Selvin S, Liaw J, et al. Acute myocardial infarction mortality in comparison with lung and bladder cancer mortality in arsenic-exposed region II of Chile from 1950 to 2000. Am J Epidemiol. 2007;166(12):1381-91.
9. Li Y, Xia Y, He L, Ning Z, Wu K, Zhao B, et al. Neurosensory effects of chronic exposure to arsenic via drinking water in Inner Mongolia: I. Signs, symptoms and pinprick testing. J Water Health. 2006;4(1):29-37.
10. Otto D, He L, Xia Y, Li Y, Wu K, Ning Z, et al. Neurosensory effects of chronic exposure to arsenic via drinking water in Inner Mongolia: II. Vibrotactile and visual function. J Water Health. 2006;4(1):39-48.
11. Tseng CH. Abnormal current perception thresholds measured by neurometer among residents in blackfoot disease-hyperendemic villages in Taiwan. Toxicol Lett. 2003;146(1):27-36.
12. Tseng CH, Chong CK, Chen CJ, Tai TY. Dose-response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in blackfoot disease endemic villages in Taiwan. Atherosclerosis. 1996;120(1-2):125-33.
13. Chen CJ, Hsueh YM, Lai MS, Shyu MP, Chen SY, Wu MM, et al. Increased prevalence of hypertension and long-term arsenic exposure. Hypertension. 1995;25(1):53-60.
14. Chen CJ, Wang SL, Chiou JM, Tseng CH, Chiou HY, Hsueh YM, et al. Arsenic and diabetes and hypertension in human populations: A review. Toxicol Appl Pharmacol. 2007;222(3):298-304.
15. Wang CH, Jeng JS, Yip PK, Chen CL, Hsu LI, Hsueh YM, et al. Biological gradient between long-term arsenic exposure and carotid atherosclerosis. Circulation. 2002;105(15):1804-9.
16. Chang CC, Ho SC, Tsai SS, Yang CY. Ischemic heart disease mortality reduction in an arseniasis-endemic area in southwestern Taiwan after a switch in the tap-water supply system. J Toxicol Environ Health A. 2004;67(17):1353-61.
17. Balakumar P, Kaur J. Arsenic exposure and cardiovascular disorders: an overview. Cardiovasc Toxicol. 2009;9(4):169-76.
18. Hall JC, Harruff R. Fatal cardiac arrhythmia in a patient with interstitial myocarditis related to chronic arsenic poisoning. South Med J. 1989;82(12):1557-60.
19. Little RE, Kay GN, Cavender JB, Epstein AE, Plumb VJ. Torsade de pointes and T-U wave alternans associated with arsenic poisoning. Pacing Clin Electrophysiol. 1990;13(2):164-70.
20. Ficker E, Kuryshev YA, Dennis AT, Obejero-Paz C, Wang L, Hawryluk P, et al. Mechanisms of arsenic-induced prolongation of cardiac repolarization. Mol Pharmacol. 2004;66(1):33-44.
21. Ohnishi K, Yoshida H, Shigeno K, Nakamura S, Fujisawa S, Naito K, et al. Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia. Ann Intern Med. 2000;133(11):881-5.
22. Chen CJ, Wu MM, Lee SS, Wang JD, Cheng SH, Wu HY. Atherogenicity and carcinogenicity of high-arsenic artesian well water. Multiple risk factors and related malignant neoplasms of blackfoot disease. Arteriosclerosis. 1988;8(5):452-60.
23. Engel RR, Hopenhayn-Rich C, Receveur O, Smith AH. Vascular effects of chronic arsenic exposure: a review. Epidemiol Rev. 1994;16(2):184-209.
24. James KA, Byers T, Hokanson JE, Meliker JR, Zerbe GO, Marshall JA. Association between lifetime exposure to inorganic arsenic in drinking water and coronary heart disease in Colorado residents. Environ Health Perspect. 2015;123(2):128-34.
25. Moon KA, Guallar E, Umans JG, Devereux RB, Best LG, Francesconi KA, et al. Association between exposure to low to moderate arsenic levels and incident cardiovascular disease. A prospective cohort study. Ann Intern Med. 2013;159(10):649-59.
26. Moon K, Guallar E, Navas-Acien A. Arsenic exposure and cardiovascular disease: an updated systematic review. Curr Atheroscler Rep. 2012;14(6):542-55.
27. Ma HZ, Xia YJ, Wu KG, Calderon R. Human exposure to arsenic and health effects in Bayingnormen, Inner Mongolia. In: Chappell WR, Abernathy CO, editors. Arsenic Exposure and Health Effects III. Amsterdam: Elsevier; 1999. p. 127-31.
28. Wade TJ, Xia Y, Wu K, Li Y, Ning Z, Le XC, et al. Increased Mortality Associated with Well-Water Arsenic Exposure in Inner Mongolia, China. Int J Environ Res Public Health. 2009;6:1107-23.
29. Xia Y, Wade TJ, Wu K, Li Y, Ning Z, Le XC, et al. Well water arsenic exposure, arsenic induced skin-lesions and self-reported morbidity in Inner Mongolia. Int J Environ Res Public Health. 2009;6(3):1010-25.
30. Sun TZ, Wu KG, Xing CM, Ma HZ, Yu GJ, Li YH, et al. Epidemiological Investigation of Arsenicism of Endemic area in Inner Mongolia. Chinese J Endemiol. 1995;Special supplement:1-4 [In Chinese].
31. Meharg AA, Williams PN, Adomako E, Lawgali YY, Deacon C, Villada A, et al. Geographical variation in total and inorganic arsenic content of polished (white) rice. Environ Sci Technol. 2009;43(5):1612-7.
32. Mo J, Xia Y, Wade TJ, Schmitt M, Le XC, Dang R, et al. Chronic arsenic exposure and oxidative stress: OGG1 expression and arsenic exposure, nail selenium, and skin hyperkeratosis in Inner Mongolia. Environ Health Perspect. 2006;114(6):835-41.
33. Bruce R, Hornsten T. Exercise stress testing in evaluation of patients with ischemic heart disease. Prog Cardiovasc Dis. 1969;11(5):371-90.
34. Schmitt MT, Schreinemachers D, Wu K, Ning Z, Zhao B, Le XC, et al. Human nails as a biomarker of arsenic exposure from well water in Inner Mongolia: comparing atomic fluorescence spectrometry and neutron activation analysis. Biomarkers. 2005;10(2-3):95-104.
35. Heydorn K. Neutron activation analysis for clinical trace element research - volumes I & II. CRS Press. 1984;1:2.
36. Gong Z, Lu X, Watta C, Wena B, Hea B, Mumford J, et al. Speciation analysis of arsenic in groundwater from Inner Mongolia with an emphasis on acid-leachable particulate arsenic. Analytical Chimica Acta. 2006;555:181-7.
37. Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr. 1974;19(6):716-23.
38. U.S. EPA: National Primary Drinking Water Regulations; Arsenic and Clarifications to Compliance and New Source Contaminants Monitoring. 40 CFR Parts 141 and 142 Federal Register; 2001: Vol. 66, No.19, 50961.
39. World Health Organization. Guidelines for drinking-water quality. Fourthth ed. Geneva: World Health Organization; 2011. p. 564.
40. Mordukhovich I, Wright RO, Amarasiriwardena C, Baja E, Baccarelli A, Suh H, et al. Association between low-level environmental arsenic exposure and QT interval duration in a general population study. Am J Epidemiol. 2009;170(6):739-46.
41. Chen Y, Santella RM, Kibriya MG, Wang Q, Kappil M, Verret WJ, et al. Association between arsenic exposure from drinking water and plasma levels of soluble cell adhesion molecules. Environ Health Perspect. 2007;115(10):1415-20.
42. Chen Y, Wu F, Liu M, Parvez F, Slavkovich V, Eunus M, et al. A prospective study of arsenic exposure, arsenic methylation capacity, and risk of cardiovascular disease in Bangladesh. Environ Health Perspect. 2013;121(7):832-8.
43. Medrano MA, Boix R, Pastor-Barriuso R, Palau M, Damian J, Ramis R, et al. Arsenic in public water supplies and cardiovascular mortality in Spain. Environ Res. 2010;110(5):448-54.
44. Kwok RK, Mendola P, Liu ZY, Savitz DA, Heiss G, Ling HL, et al. Drinking water arsenic exposure and blood pressure in healthy women of reproductive age in Inner Mongolia, China. Toxicol Appl Pharmacol. 2007;222(3):337-43.